Cancer group loses landmark case against gene patent

A CANCER group which fought against the patenting of the BRCA1 gene has lost its landmark case in the Federal Court but may appeal the decision.

Please Login to Access Medical Observer

If you have an account select Login. If you are new to Medical Observer select Join.

Login Join


Niamh Mullen

Niamh Mullen is a medical writer and former news director of MO.


Guest Writer